112 results on '"Krippner‐Heidenreich, Anja"'
Search Results
2. Acute myeloid leukemias with UBTF tandem duplications are sensitive to menin inhibitors
3. Targeting Death Receptor 5 (DR5) for the imaging and treatment of primary bone and soft tissue tumors: an update of the literature.
4. Targeting Death Receptor 5 (DR5) for imaging and treatment of primary bone and soft tissue tumors: an update of the literature.
5. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML
6. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1
7. The neuronal homeobox transcription factor HMX3 is a crucial vulnerability factor in MECOM-negative KMT2A::MLLT3 acute myelomonocytic leukemia
8. P444: SINGLE CELL RNASEQ UNCOVERING THE ROLE OF A LEUKEMIC DRIVER GENE FUSION CBFΒ::MYH11 IN THE LEUKEMIC–NICHE SIGNALING
9. P437: EFFECTIVE IMMUNOTHERAPY OF PEDIATRIC T(8;21) ACUTE MYELOID LEUKEMIA BY REPURPOSING CD3XCD19 TARGETING BISPECIFIC ANTIBODIES
10. TNF-related apoptosis-inducing ligand (TRAIL) for bone sarcoma treatment: Pre-clinical and clinical data
11. Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles
12. Acute myeloid leukemias with UBTFtandem duplications are sensitive to menin inhibitors
13. Leukemic stem cells hijack lineage inappropriate signalling pathways to promote their growth
14. The MLL-Menin Interaction is a Therapeutic Vulnerability in NUP98 -rearranged AML
15. Increased Bone Marrow Uptake and Accumulation of Very-Late Antigen-4 Targeted Lipid Nanoparticles
16. Inhibition of the Menin-MLL1 Interaction in MLL-Rearranged Primary Mixed-Phenotype Acute Leukemia Samples Promotes Leukemic Differentiation
17. Tumor Necrosis Factor
18. FasL and Fas : Typical Members of the TNF Ligand and Receptor Family
19. The Critical Role of TAK1 in Accentuated Epithelial to Mesenchymal Transition in Obliterative Bronchiolitis after Lung Transplantation
20. 3098 – RUNX1/RUNX1T1 ORCHESTRATES THE LEUKAEMIC MICROENVIRONMENT
21. RUNX1::RUNX1T1 Impairs the Differentiation Potential of Primary AML Cells
22. Tumor necrosis factor–costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts
23. Tumour necrosis factor α RECEPTOR activated T cells of patients with systemic sclerosis are deficient in IL-10 expression but promote myofibroblast differentiation via IL-6 and TGF-β
24. TNF-alpha-induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-alpha blockade-driven IL-17A expression
25. TNF-α–induced protein 3 (TNFAIP3) /A20 acts as a master switch in TNF-α blockade–driven IL-17A expression
26. Dendritic cell maturation and survival are differentially regulated by TNF receptors 1 and 21
27. TNF-α–induced protein 3 (TNFAIP3)/A20 acts as a master switch in TNF-α blockade–driven IL-17A expression.
28. Dendritic Cell Maturation and Survival Are Differentially Regulated by TNFR1 and TNFR2
29. FasL and Fas
30. Tumor Necrosis Factor
31. A8.2 An unconventional anti-inflammatory role for TNF recpetor (TNFR)1 in tregs: TNFR1 and 2 differetnialy modulate FOXP3+ TREG function
32. The Transmembrane Domains of TNF-Related Apoptosis-Inducing Ligand (TRAIL) Receptors 1 and 2 Co-Regulate Apoptotic Signaling Capacity
33. The Tumor Necrosis Factor Receptor Stalk Regions Define Responsiveness to Soluble versus Membrane-Bound Ligand
34. Ligand-induced internalization of TNF receptor 2 mediated by a di-leucin motif is dispensable for activation of the NFκB pathway
35. Single chain TNF derivatives with individually mutated receptor binding sites reveal differential stoichiometry of ligand receptor complex formation for TNFR1 and TNFR2
36. Fluorescence correlation spectroscopy reveals topological segregation of the two tumor necrosis factor membrane receptors
37. Dual function of cysteine rich domain (CRD) 1 of TNF receptor type 1: Conformational stabilization of CRD2 and control of receptor responsiveness
38. Nanoscale Arrangement of Apoptotic Ligands Reveals a Demand for a Minimal Lateral Distance for Efficient Death Receptor Activation
39. Single-Chain TNF, a TNF Derivative with Enhanced Stability and Antitumoral Activity
40. Tumour Necrosis Factors
41. Tumor Necrosis Factor (TNF)-Functionalized Nanostructured Particles for the Stimulation of Membrane TNF-Specific Cell Responses
42. Caspase-Dependent Regulation and Subcellular Redistribution of the Transcriptional Modulator YY1 during Apoptosis
43. The Met-196 → Arg Variation of Human Tumor Necrosis Factor Receptor 2 (TNFR2) Affects TNF-α-induced Apoptosis by Impaired NF-κB Signaling and Target Gene Expression
44. Control of Receptor-induced Signaling Complex Formation by the Kinetics of Ligand/Receptor Interaction
45. FasL and Fas.
46. Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1
47. Inhibition of Proliferation and Apoptosis by the Transcriptional Repressor Mad1
48. Repurposing CD19-directed immunotherapies for pediatric t(8;21) acute myeloid leukemia.
49. Combining CRISPR-Cas9 and TCR exchange to generate a safe and efficient cord blood-derived T cell product for pediatric relapsed AML.
50. Targeting pediatric cancers via T-cell recognition of the monomorphic MHC class I-related protein MR1.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.